$SDST

Stardust Power Announces Q1 2026 Financial Results

Stardust Power Inc. (Nasdaq: SDST) announced its financial results for the quarter ended March 31, 2026, and provided an update on its lithium refinery project in Muskogee, Oklahoma. Key business updates include securing an air quality construction permit, entering into a Letter of Intent for up to $150 million in project-level financing, and expanding its domestic feedstock pipeline. The company reported a net loss of $5.2 million for the quarter, largely due to warrant liabilities and debt financing expenses, and held approximately $1.2 million in cash and cash equivalents.

Original reporting
Published May 14, 2026, 8:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 14, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stardust Power Announces Q1 2026 Financial Results — source image
Decision brief

The 30-second read

$SDSTNeutralLow
01

Why it matters

Financial results highlight operational challenges, but project updates suggest potential for future growth.

02

Market read

The news is relevant to investors interested in renewable energy and lithium markets, but limited in immediate trading impact.

03

What to watch

Potential future revenue from the lithium refinery and other projects not yet reflected in current financials.

Timing: short-term (next 1-2 weeks)

Background

Stardust Power is engaged in power generation and lithium refining, with recent focus on project development in Oklahoma.

Company-level read

Ticker impact

$SDSTNeutralMedium confidence
Context

Primary focus due to recent financial results and project updates.

Expected impact

Potential short-term decline followed by stabilization as investors digest the loss and positive project developments.

Evidence & confidence

Financial loss and cash position are negative factors; however, project progress and financing plans suggest future growth potential. Limited current stock price data restricts precise technical analysis.

Market effects

Potentially negative impact on renewable energy and power generation sectors due to financial losses.

Limited; primarily affects investors in Stardust Power and related regional markets.

negligible; company-specific news with minimal global impact.

Counterpoint

The company’s progress on project permits and financing could lead to a turnaround, making the stock a speculative buy for risk-tolerant traders.

Key entities

  • Stardust Power Inc.

    A power and energy company focusing on renewable energy and lithium refining.

  • Muskogee Lithium Refinery Project

    A significant lithium refinery project in Oklahoma aiming to supply the growing battery market.

Related articles

$SDSTMed

Stardust Power signs lithium supply deal with Charge CCCV

Stardust Power (NASDAQ: SDST) said it signed a non-binding Letter of Intent with battery technology firm Charge CCCV LLC (C4V) to supply battery-grade lithium carbonate from its Muskogee, Oklahoma refinery. C4V’s preliminary demand forecast calls for 3,000 MT in 2028, 10,000 MT in 2029, and 20,000 MT by 2030. Stardust noted the deal could cover much of planned output and generate billions if prices stay near current levels.

$ELMed

Estee Lauder outlook revised to stable by S&P on deleveraging

S&P Global Ratings revised Estee Lauder's outlook to stable from negative, citing improved operating results and credit metrics. The agency expects adjusted leverage to fall to 1.9x by fiscal 2027, with mid-single-digit revenue growth and expanded EBITDA margins. Cash flows are projected to decline due to restructuring and investments, but the company plans to use cash balances for debt repayment.

$AZNMedAI 8/10

AstraZeneca’s Oncology Engine Faces a Key Test After Camizestrant Miss

AstraZeneca's breast cancer drug camizestrant (Etcamah) failed to meet the primary endpoint in the Phase III SERENA-4 trial, missing a key growth opportunity. The trial showed no statistically significant improvement in progression-free survival. AstraZeneca's shares fell 3% in after-hours trading. The drug remains approved for ESR1-mutated patients, with strong Phase III data supporting this indication. AstraZeneca's overall oncology portfolio and pipeline remain robust, with first-half 2026 re

$LHXHigh

L3Harris Is Down 30% and Guggenheim Calls It a Buy

L3Harris Technologies (LHX) gained 0.43% premarket after Guggenheim initiated coverage with a Buy rating and $365 price target, suggesting 49% upside. The stock is near its 52-week low, down 30% in six months. Guggenheim expects sustained growth and defense spending tailwinds. Jefferies started coverage at Hold with a $315 target, citing leadership changes and missile IPO uncertainty.

$ABNBMedAI 8/10

Airbnb attempts to flip affordability script with $250M housing fund

Airbnb announced a $250 million fund to support affordable and mixed-income housing projects, according to the Wall Street Journal. The company aims to address criticism over its role in housing affordability. Funds will be distributed as gap financing, with the first project in Austin, Texas, receiving $6.4 million. Airbnb expects below-market returns but anticipates the investment will leverage $5 billion in capital over a decade. The initiative is led by former Biden administration official D